RebelBio was one of several SOSV-backed startup accelerators, and focused on biotech, healthtech, and life sciences. RebelBio offered funding, co-working space, mentorship, and access to the RebelBio network of alumni, investors, corporate partners, and media partners. RebelBio began in 2014 in Cork, Ireland and relocated to the Imperial College of London in 2018 for a more business-friendly environment. It merged with SOSV’s IndieBio brand in 2020 and is now based in New York City.
During RebelBio's accelerator program, startup teams competed to be selected. Once selection was complete, each team member was referred to as a "rebel" for the duration of the program. The teams headed to Imperial College London for RebelBio's three-month accelerator program. Their accelerator program encouraged scientists to participate, and attempted to transform them into entrepreneurs. Each accelerator cohort finished with Investor Month, a month where teams get to pitch their businesses to investors in hope of receiving more funding and create important business connections.
RebelBio's third cohort in 2016 consisted of: Anu Dairy, Cell Reserves Inc, Chinova Bioworks, The Banana Chronicle, Helixworks, Hexafly, Magenta Biolabs, MicroSynbiotiX, MilisBio, Moirai Biodesign, Spira, and Unibiome.
RebelBio's fourth cohort in 2017 consisted of: Alternative Plants, Canuevo Biotech, Cell Free Tech, CyCa OncoSolutions, Hemoalgae, Galactica Biotech, Khonsu Therapeutics, NuLeaf Tech, OaCP S.R.L, Phyteau, Plantedit, SwaLife Biotech, and VALANX Biotech.
Chief Scientific Officer
Rodrigo Mallo Leiva
Associate Director & Program Manager
Scientist in Residence
15 life sciences start-ups to watch at RebelBio Demo Day 2017
RebelBio and Imperial College London join forces to accelerate the next generation of life sciences startups
David Barreto Ian
SOSV looks to raise $250m to help early-stage start-ups
What Startup Accelerators Really Do
With a focus on life sciences, RebelBio has incubated more than 50 startups
Documentaries, videos and podcasts
42 Questions with RebelBio - How to build the future with biology
October 1, 2017
CEOs of the Biotech future! What start ups are shaking up RebelBio?
March 13, 2018
Elsa Sotiriadis on Moonshots (RebelBioFuture)
March 16, 2017
RebelBio Demo Day 2017
August 23, 2017
Reinventing biotech startup acceleration - Fireside Chat with Steve O'Connell from RebelBio
July 12, 2017
Controlled Natural Fermentations
Next Generation Industrial Plastic Waste Upcycling
Cell Reserves Inc
Biomolecular shields for therapeutic molecules
Personalised Epigenetic's & Wellness Testing
Simple to Use Diagnostics for Neglected Tropical Diseases
Yeast Derived Endo- cannabinoids
On-site Nucleotide Synthesis
Cellular Agriculture Alternative Milk Product
Biotechnology Colour Pigments
Crowdsourced Drug Discovery
Cellular Agriculture Derived LAL for Pyrogen Testing
- Startup acceleratorSupport startups with funding, mentoring, training and events for a definite period (usually three months), in exchange for equity.
- StartupA startup company is an entrepreneurial venture in the initial stage of its operations. Startups are typically young businesses aiming to grow quickly and meet a marketplace need by developing or offering an innovative product, process or service.
- IndieBioA startup accelerator for biotechnology companies located in San Francisco, California.
- SOSVSOSV (formerly SOS Ventures) is a venture capital firm founded in 1995 by Sean O'Sullivan that provides growth, seed, and venture capital funding to startups. SOSV runs six seed accelerator programs: HAX Accelerator, Chinaccelerator, MOX, IndieBio, RebelBio, and Food-X.
- Y CombinatorY Combinator (also known as YC) is a US based seed accelerator, which was started in March 2005.
- Cellular agricultureCellular agriculture is an interdisciplinary scientific field drawing from several disciplines such as synthetic biology, genetic engineering, molecular biology, tissue engineering, biochemistry, and food science to design organisms capable of producing a wide variety of agricultural products.